Market Place
Sourcing Support
Everest Medicines Announces Commercial Launch and First Prescription for XERAVA
26 Jul 2023 //
PR NEWSWIRE
Everest Medicines Announces Approval of Xerava in China
17 Mar 2023 //
PR NEWSWIRE
La Jolla Announces Data on XERAVA to be Presented at IDWeek 2022
14 Oct 2022 //
BUSINESSWIRE
Everest Medicines Announces Approval of XERAVA in Hong Kong
07 Oct 2022 //
PRNEWSWIRE
Everest Medicines gets China NMPA approval to begin phase 3 trial of Xeravam
06 Aug 2021 //
PHARMABIZ
La Jolla Company Announces Exclusive Licensing Agreement for GIAPREZA™
12 Jan 2021 //
NASDAQ
SOM Biotech announces poster presentation on the repurposing of Eravacycline
22 Oct 2020 //
PRNEWSWIRE
La Jolla Company Announces the Closing of Acquisition of Tetraphase
28 Jul 2020 //
GLOBENEWSWIRE
Tetraphase Announces Receipt of Proposal from La Jolla Pharmaceutical Company
22 Jun 2020 //
BUSINESSWIRE
As it happened: A bidding war for an antibiotic maker in a market
05 Jun 2020 //
ENDPTS
Tetraphase Announces Receipt of Amended Melinta Proposal, to AcelRx
01 Jun 2020 //
BUSINESSWIRE
Tetraphase Announces Receipt of Amended Melinta Proposal, Notice to AcelRx
28 May 2020 //
BUSINESSWIRE
Tetraphase Announces Determination of Superior Offer and Notice to AcelRx
21 May 2020 //
BUSINESSWIRE
Tetraphase Pharmaceuticals Announces Completion of $8M
01 Nov 2019 //
BUSINESSWIRE
Tetraphase Pharmaceuticals to Present XERAVA™ (Eravacycline) Data at IDWeek 2019
25 Sep 2019 //
BIOSPACE
Tetraphase plots Q4 launch for 1st antibiotic after OK for eravacycline
28 Aug 2018 //
ENDPTS
Novartis Taps Shyft Analytics To Drive Company`s Digital Transformation
26 Jul 2018 //
BIOSPACE
Tetraphase Pharmaceuticals Announces Submission of NDA to FDA for Eravacycline
02 Jan 2018 //
GLOBENEWSWIRE
Novasep moves eravacycline API to commercial-scale production
14 Dec 2017 //
FIERCE PHARMA
Novasep to supply ingredient for Tetraphase`s candidate superbug eravacycline
13 Dec 2017 //
IN PHARMATECHNOLOGIST
Novasep Signs Manufacturing Agreement with Clinical-stage for Eravacycline API
12 Dec 2017 //
PRESS RELEASE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.